» Articles » PMID: 26094109

Microfluidic 3D Cell Culture: from Tools to Tissue Models

Overview
Publisher Elsevier
Specialty Biotechnology
Date 2015 Jun 22
PMID 26094109
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

The transition from 2D to 3D cell culture techniques is an important step in a trend towards better biomimetic tissue models. Microfluidics allows spatial control over fluids in micrometer-sized channels has become a valuable tool to further increase the physiological relevance of 3D cell culture by enabling spatially controlled co-cultures, perfusion flow and spatial control over of signaling gradients. This paper reviews most important developments in microfluidic 3D culture since 2012. Most efforts were exerted in the field of vasculature, both as a tissue on its own and as part of cancer models. We observe that the focus is shifting from tool building to implementation of specific tissue models. The next big challenge for the field is the full validation of these models and subsequently the implementation of these models in drug development pipelines of the pharmaceutical industry and ultimately in personalized medicine applications.

Citing Articles

Three-Dimensional Models: Biomimetic Tools That Recapitulate Breast Tissue Architecture and Microenvironment to Study Ductal Carcinoma In Situ Transition to Invasive Ductal Breast Cancer.

Shah S, Osuala K, Brock E, Ji K, Sloane B, Mattingly R Cells. 2025; 14(3).

PMID: 39937011 PMC: 11817749. DOI: 10.3390/cells14030220.


Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review).

Isinelli G, Failla S, Plebani R, Prete A Med Int (Lond). 2025; 5(2):13.

PMID: 39790707 PMC: 11707505. DOI: 10.3892/mi.2024.212.


Perspective of 3D culture in medicine: transforming disease research and therapeutic applications.

Park C, Park J, Suh Y Front Bioeng Biotechnol. 2025; 12:1491669.

PMID: 39749112 PMC: 11693738. DOI: 10.3389/fbioe.2024.1491669.


A Versatile Microfluidic Device System that Lacks a Synthetic Extracellular Matrix Recapitulates the Blood-Brain Barrier and Dynamic Tumor Cell Interaction.

Santillan-Cortez D, Castell-Rodriguez A, Gonzalez-Arenas A, Suarez-Cuenca J, Perez-Koldenkova V, Anorve-Bailon D Bioengineering (Basel). 2024; 11(10).

PMID: 39451383 PMC: 11505467. DOI: 10.3390/bioengineering11101008.


Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model.

Payasi A, Yadav M, Chaudhary S, Aggarwal A Antimicrob Agents Chemother. 2024; 68(10):e0021924.

PMID: 39225483 PMC: 11459911. DOI: 10.1128/aac.00219-24.